<DOC>
	<DOCNO>NCT00273299</DOCNO>
	<brief_summary>The purpose study ass potential use valsartan/HCTZ initial therapy patient severe hypertension compare valsartan alone initial therapy , determine whether great proportion patient achieve blood pressure control combination compare monotherapy without produce unacceptable adverse event profile .</brief_summary>
	<brief_title>Valsartan/Hydrochlorothiazide Combination Treatment Severe Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Diagnosed severe hypertension Inability discontinue prior antihypertensive medication Heart failure kind History stroke , transient ischemic attack , myocardial infarction , chest pain , abnormal heart rhythm Liver , kidney , pancreas disease Diabetes poor glucose control Allergy certain medication use treat high blood pressure Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>high blood pressure</keyword>
	<keyword>valsartan/hydrochlorozide</keyword>
	<keyword>severe hypertension</keyword>
</DOC>